Home  |   Archive  |   Online Submission  |   News & Events  |   Subscribe  |   APFA  |   Society  |   Contact Us  |   中文版
Search   
 
Journal

Ahead of print
Authors' Accepted
    Manuscripts
new!
Current Issue
Archive
Acknowledgments
Special Issues
Browse by Category

Manuscript Submission

Online Submission
Online Review
Instruction for Authors
Instruction for Reviewers
English Corner new!

About AJA

About AJA
Editorial Board
Contact Us
News

Resources & Services

Advertisement
Subscription
Email alert
Proceedings
Reprints

Download area

Copyright licence
EndNote style file
Manuscript word template
Guidance for AJA figures
    preparation (in English)

Guidance for AJA figures
    preparation (in Chinese)

Proof-reading for the
    authors

AJA Club (in English)
AJA Club (in Chinese)

 
Abstract

Volume 23, Issue 1 (January 2021) 23, 1–2; 10.4103/aja.aja_35_20

The emerging role of prostate-specific membrane antigen (PSMA) PET-CT in patients with high-risk prostate cancer: moving the bar in high-risk prostate cancer

Jeanny B Aragon-Ching

GU Medical Oncology, Department of Oncology, Inova Schar Cancer Institute, Fairfax, VA, USA

Correspondence: Dr. JB Aragon-Ching (jeanny. aragon-ching@inova.org)

Date of Submission 12-Apr-2020 Date of Acceptance 20-Apr-2020 Date of Web Publication 24-Jul-2020

Abstract

Full Text | PDF |

 
Browse:  127
 
Copyright 1999-2017  Shanghai Materia Medica, Shanghai Jiao Tong University.  All rights reserved